Plasma EVs from depression patients improve depressive behaviour induced by inflammation through the transmission of Sig-1R, and the injection of EVs from depression model mice or depression patients significantly improves the reduced BDNF expression, neuro-inflammation, and depressive behaviour of mice stimulated with lipopolysaccharide (34, 53). Here, SIGMAR1 is linked to depressive disorder.